AS
BEAT

Altshuler Shaham’s BioTelemetry, Inc. BEAT Stock Holding History

Altshuler Shaham’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-18,463
Closed -$1.33M – 564
2020
Q4 		$1.33M Buy
18,463
+8,563
+86% +$448K 0.03% 63
2020
Q3 		$451K Sell
9,900
-6,258
-39% -$262K 0.01% 128
2020
Q2 		$730K Buy
16,158
+9,900
+158% +$444K 0.02% 82
2020
Q1 		$241K Buy
6,258
+958
+18% +$44.1K 0.01% 118
2019
Q4 		$246K Buy
5,300
+400
+8% +$17.3K 0.01% 152
2019
Q3 		$200K Buy
4,900
+200
+4% +$8.63K 0.01% 164
2019
Q2 		$807K Buy
4,700
+1,683
+56% +$88.5K 0.03% 88
2019
Q1 		$57K Buy
3,017
+696
+30% +$47.8K ﹤0.01% 120
2018
Q4 		$42K Buy
2,321
+2,204
+1,884% +$132K ﹤0.01% 130
2018
Q3 		$8K Sell
117
-383
-77% -$21.4K ﹤0.01% 191
2018
Q2 		$6K Buy
+500
New +$19.9K ﹤0.01% 172

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Altshuler Shaham's BEAT Position: Q1 2021 in Review

Altshuler Shaham sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 18,463 shares — an estimated $1.33M sold.

Altshuler Shaham first reported a position in BEAT in Q2 2018 and held it in 11 quarters. The position peaked at $1.33M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Altshuler Shaham reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Altshuler Shaham sold 18,463 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.33M.
  • Altshuler Shaham first reported a position in BioTelemetry, Inc. in Q2 2018 and held it in 11 quarters.
  • Altshuler Shaham's BioTelemetry, Inc. position peaked at $1.33M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Altshuler Shaham's 13F filing for Q1 2021, filed 13 May 2021.